Medicine composition for treating psoriasis

Abstract

The invention discloses a medicine composition for treating psoriasis, which is prepared by the following raw materials according to the weight portion: 150-200 portions of blackberry lily, 300-400 portions of subprostrate sophora, 200-300 portions of honeysuckle, 150-200 portions of cotex dictamni, 300-600 portions of china root, 100-200 portions of paris polyphylla, 300-500 portions of oldenlandia diffusa, 200-300 portions of herba scutellariae barbatae, 300-400 portions of radix arnebiae seu lithospermi, 150-200 portions of ebony, 150-200 portions of nutgall, 300-500 portions of hoantchy root, 300-500 portions of motherwort, 100-200 portions of rhubarb, 200-300 portions of salvia miltiorrhiza and 150-200 portions of liquorice. The invention is prepared by pure Chinese medicinal herbs and has remarkable treatment effect and no side effect to the patient; it is clinically proved that the cure rate reaches more than 90 percent without easy recrudescence.

Description

technical field [0001] The invention belongs to the field of medicine, in particular to a pharmaceutical composition for treating psoriasis. Background technique [0002] Psoriasis is a common inflammatory skin disease characterized by scaly skin lesions, clinically manifested as red papules or plaques, covered with silvery white scales on the skin surface, causing local skin thickening, commonly known as psoriasis . According to the clinical and pathological characteristics of psoriasis, it can generally be divided into vulgar, arthritis, and pustular types. There is no effective method for the treatment of psoriasis. It is a kind of antineoplastic drug, which is a cytotoxic drug used in the treatment of psoriasis earlier. It is suitable for arthritis type, erythrodermic type, pustular psoriasis and generalized psoriasis vulgaris. The toxic reaction is severe, which can cause extensive fibrosis and cirrhosis of the liver, and has an inhibitory effect on the hematopoietic ...

AI Technical Summary

Problems solved by technology

According to the clinical and pathological characteristics of psoriasis, it can generally be divided into vulgar, arthritis, and pustular types. There is no effective method for the treatment of psoriasis. It is a kind of antineoplastic drug, which is a cytotoxic drug used in the treatment of psoriasis earlier. It is suitable for arthritis type, erythrodermic type, pustular psoriasis and generalized psoriasis vulgaris. The toxic reaction is severe, which can cause extensive fibrosis and cirrhosis of the liver, and has an inhibitory effect on the hematopoietic system, mainly manifested as a decrease in white blood cells, and also affects platelets. It is called diketopazine, which mainly inhibits the synthesis of deoxyribonucleic acid in cells, thereby producing the effect of inhibiting cell growth. Its main side effect is bone marrow suppression, causing leukopenia and thrombocytopenia; the third is corticosteroid hormones, although corticosteroid hormones treat various Psoriasis type psoriasis has a good curative effect, but the application dose is large and the time is long, which will cause serious side effects of hormones, and cause severe psoriasis recurrence or pustular psoriasis after reduction or withdrawal